Pic

Covetrus, Inc.

$CVET
$20.84
Капитализция: $2.9B
Показать больше информации о компании

О компании

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small показать больше
equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.
Перевод автоматический

показать меньше

Отчетность

03.11.2021, 23:08 EPS за 3 квартал составил ХХ, консенсус YY

04.08.2021, 23:12 Прибыль на акцию за 2 квартал XX, консенсус-прогноз YY
Квартальная отчетность будет доступна после Регистрации

Прогнозы аналитиков

Аналитик Аарон Кесслер поддерживает с сильной покупкой и снижает целевую цену со xxx до yyy долларов.

25.10.2021, 16:02 Аналитик Berenberg Сунил Райгопал инициирует освещение на GoDaddy с рейтингом «Покупать» и объявляет целевую цену в xxx долларов.
Прогнозы аналитиков будут доступны после Регистрации

Все новости компании Covetrus

24.06.2022, 00:55 МСК COVETRUS, INC. INVESTIGATION CONTINUES: Scott+Scott Attorneys at Law LLP Investigates Clayton, Dubilier & Rice and TPG Capital Buyout of Covetrus, Inc – CVET NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors it is investigating whether the directors of Covetrus, Inc. (“Covetrus”) (NASDAQ: CVET) breached their fiduciary duties to its shareholders in approving a buyout with funds affiliated with Clayton, Dubilier & Rice (“CD&R”) and TPG Capital (“TPG”) for inadequate consideration. If you are a Covetrus shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982, or jpettigrew@scott-scott.com.Covetrus, INC. РАССЛЕДОВАНИЕ ПРОДОЛЖАЕТСЯ: Scott+Scott Attorneys at Law LLP расследует выкуп Clayton, Dubilier & Rice и TPG капитала Covetrus, Inc – CVET НЬЮ-ЙОРК – (BUSINESS WIRE) – Scott+Scott Attorneys at Law LLP («Scott+Scott»), международная фирма, занимающаяся судебными разбирательствами по ценным бумагам и правам потребителей, напоминает инвесторам, что расследует, не являются ли директора Covetrus, Inc. («Covetrus ») (NASDAQ: CVET) нарушили свои фидуциарные обязанности перед своими акционерами, одобрив выкуп акций фондами, аффилированными с Clayton, Dubilier & Rice («CD&R») и TPG Capital («TPG») за ненадлежащее рассмотрение. Если вы являетесь акционером Covetrus, вы можете связаться с адвокатом Джо Петтигрю для получения дополнительной информации по бесплатному телефону 844-818-6982 или по электронной почте jpettigrew@scott-scott.com.

07.06.2022, 00:02 МСК Scott+Scott Attorneys at Law LLP Investigates Clayton, Dubilier & Rice and TPG Capital Buyout of Covetrus, Inc – CVET NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the directors of Covetrus, Inc. (“Covetrus”) (NASDAQ: CVET) breached their fiduciary duties to its shareholders in approving a buyout with funds affiliated with Clayton, Dubilier & Rice (“CD&R”) and TPG Capital (“TPG”) for inadequate consideration. If you are a Covetrus shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982, or jpettigrew@scott-scott.com.Scott+Scott Attorneys at Law LLP расследует дело о выкупе Clayton, Dubilier & Rice и TPG Capital компании Covetrus, Inc – CVET НЬЮ-ЙОРК -- (BUSINESS WIRE) --Scott+Scott Attorneys at Law LLP (“Скотт+Скотт”), международная юридическая фирма по ценным бумагам и защите прав потребителей, расследует, нарушили ли директора Covetrus, Inc. (“Covetrus”) (NASDAQ: CVET) свои фидуциарные обязанности перед акционерами в одобрение выкупа акций фондами, аффилированными с Clayton, Dubilier & Rice (“CD&R”) и TPG Capital (“TPG”), за ненадлежащее вознаграждение. Если вы являетесь акционером Covetrus, вы можете связаться с адвокатом Джо Петтигрю для получения дополнительной информации по бесплатному телефону 844-818-6982 или jpettigrew@scott-scott.com .

Новости переведены автоматически

Остальные 13 новостей будут доступны после Регистрации

Попробуйте все возможности сервиса Tradesense

Моментальные уведомления об измемении цен акций
Новости с официальных сайтов компаний
Отчётности компаний
События с FDA, SEC
Прогнозы аналитиков и банков
Регистрация в сервисе
Tradesense доступен на мобильных платформах